GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precigen Inc (FRA:I5X) » Definitions » Sale Of Investment

Precigen (FRA:I5X) Sale Of Investment : €162.60 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Precigen Sale Of Investment?

Precigen's sale of investment for the three months ended in Dec. 2024 was €45.86 Mil. It means Precigen gained €45.86 Mil from selling investments. Precigen's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €162.60 Mil.

Compared with last quarter (€26.72 Mil in Sep. 2024 ), Precigen gained more money from selling investments in Dec. 2024 (€45.86 Mil).


Precigen Sale Of Investment Historical Data

The historical data trend for Precigen's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precigen Sale Of Investment Chart

Precigen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 109.33 88.65 64.61 168.16 167.14

Precigen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.84 41.94 48.08 26.72 45.86

Precigen Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €162.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Precigen Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Precigen's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Precigen Business Description

Traded in Other Exchanges
Address
20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Precigen Headlines

No Headlines